Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,2676,320,1.57 [1.19-2.07],0.0015586958662372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRV1,Acrosomal protein SP-10,2244,268,1.15 [1.04-1.27],0.0067821165025328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",2616,315,1.37 [1.13-1.67],0.001229843209762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2637,320,2.23 [1.63-3.06],6.417105055701541e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,2642,314,1.93 [1.61-2.33],2.8256935802880945e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2244,268,1.42 [1.04-1.94],0.0291551447504899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2641,320,1.46 [1.12-1.90],0.0047037707277881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2307,271,2.25 [1.65-3.07],3.270910678537476e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,2637,320,2.00 [1.52-2.63],7.856493934739294e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,2674,318,2.15 [1.58-2.92],1.0932557712429004e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,2685,322,2.31 [1.78-2.99],2.4226922827365665e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,2636,313,1.21 [1.12-1.32],4.038964804869029e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,2658,316,0.46 [0.32-0.65],1.589263902070445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH1B,All-trans-retinol dehydrogenase,2268,265,0.83 [0.72-0.95],0.0074704292256749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2616,315,0.83 [0.74-0.93],0.0011937135911252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,2676,318,2.18 [1.52-3.13],2.522367020722332e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,2309,270,0.31 [0.19-0.49],1.1818091928374815e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,2633,319,0.66 [0.56-0.78],5.339949846019838e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,2570,307,1.25 [1.13-1.37],6.333362180919574e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,2674,318,1.65 [1.31-2.08],2.641306718124396e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHCY,Adenosylhomocysteinase,2658,316,0.81 [0.69-0.94],0.0054213391420202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSP,Alpha-hemoglobin-stabilizing protein,2663,320,0.85 [0.76-0.96],0.006135073936725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK1,Adenylate kinase isoenzyme 1,2658,316,0.78 [0.67-0.92],0.002841926412473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALCAM,CD166 antigen,2695,322,2.22 [1.41-3.49],0.0005507763286359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH1A1,Retinal dehydrogenase 1,2670,320,0.76 [0.65-0.90],0.0012687728196147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPI,Intestinal-type alkaline phosphatase,2244,268,1.10 [1.01-1.20],0.033083390576478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPP,"Alkaline phosphatase, placental type",2636,313,1.11 [1.01-1.22],0.0291102440307147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,2674,318,4.19 [2.70-6.50],1.8400548720775363e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,2636,313,1.71 [1.14-2.57],0.0089623026065275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOT,Angiomotin,2268,265,0.56 [0.41-0.76],0.0001862263409878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,2656,316,1.49 [1.13-1.98],0.0049614653162469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT2,Angiopoietin-2,2676,318,1.43 [1.11-1.85],0.0055921727861492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL3,Angiopoietin-related protein 3,2661,316,0.72 [0.55-0.94],0.0174376957296286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,2672,317,1.64 [1.33-2.03],4.823714691712283e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL7,Angiopoietin-related protein 7,2676,318,1.33 [1.04-1.69],0.0220472766317101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRD54,Ankyrin repeat domain-containing protein 54,2579,308,0.73 [0.60-0.89],0.0017851340308382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANPEP,Aminopeptidase N,2661,317,1.50 [1.08-2.09],0.0168006617321311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA10,Annexin A10,2589,310,1.15 [1.03-1.28],0.0118713916269286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA11,Annexin A11,2659,319,0.86 [0.75-1.00],0.0457974224385458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA4,Annexin A4,2645,315,0.86 [0.75-0.99],0.0376526973264792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,2581,309,1.76 [1.40-2.20],1.124577940721931e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,2668,319,3.63 [2.68-4.93],1.1406997791455252e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,2670,318,0.83 [0.70-0.99],0.0425807659107562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APLP1,Amyloid-like protein 1,2658,316,0.77 [0.64-0.94],0.0083143195950077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA1,Apolipoprotein A-I,2309,270,0.44 [0.26-0.74],0.0018420320316658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,2315,273,1.29 [1.04-1.60],0.0197371030248817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,2309,270,2.46 [1.86-3.26],2.8384742568560856e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOBR,Apolipoprotein B receptor,2243,264,0.74 [0.57-0.97],0.0296773948974761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,2304,270,0.49 [0.36-0.65],1.2248796287394633e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOD,Apolipoprotein D,2216,259,0.70 [0.49-0.99],0.0463411925106755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOE,Apolipoprotein E,2309,270,0.59 [0.47-0.75],1.4207682900625844e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOM,Apolipoprotein M,2666,317,0.65 [0.47-0.90],0.0103066013635568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,2636,313,2.15 [1.78-2.59],1.4334216883393664e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG1,Arginase-1,2622,315,0.80 [0.66-0.97],0.0199187730632805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,2668,319,1.66 [1.30-2.13],6.110711258561319e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,2641,320,1.48 [1.10-1.99],0.0099216224304702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,2315,273,1.74 [1.15-2.62],0.0082816098143283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG4A,Cysteine protease ATG4A,2579,308,0.83 [0.70-0.99],0.0339644355033042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,2242,265,1.27 [1.02-1.57],0.0291510293101323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1F,V-type proton ATPase subunit F,2584,309,0.80 [0.69-0.94],0.0070481476555857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2307,271,2.07 [1.51-2.84],6.491350792670251e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,2668,319,1.59 [1.14-2.23],0.0067425730333084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,2309,270,1.87 [1.33-2.63],0.0003500773197892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2243,264,3.03 [2.21-4.16],5.638671086035029e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",2674,318,2.11 [1.52-2.93],7.708265649061655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,2579,308,1.63 [1.27-2.09],0.0001213212276945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAM,Basal cell adhesion molecule,2670,320,1.85 [1.26-2.74],0.0019131352429144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,2641,320,0.48 [0.37-0.63],9.401628508220585e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",2244,266,0.71 [0.53-0.95],0.0196181088051066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2664,320,1.66 [1.28-2.17],0.0001741864363865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,2316,272,0.69 [0.62-0.78],2.1062109935110926e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLMH,Bleomycin hydrolase,2695,322,0.74 [0.55-0.99],0.0459562020653903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,2268,265,2.17 [1.39-3.39],0.0006617276726694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,2616,315,2.80 [1.87-4.18],5.152575168432474e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA2_BOLA2B,BolA-like protein 2,2243,264,0.77 [0.61-0.95],0.0171219515964325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB2,BPI fold-containing family B member 2,2301,270,0.75 [0.63-0.90],0.0017903495664642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,2686,319,2.05 [1.33-3.16],0.0010771230096119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,2674,318,2.52 [1.87-3.40],1.079707829645807e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C19orf12,Protein C19orf12,2589,310,0.84 [0.74-0.97],0.0156210741135463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QA,Complement C1q subcomponent subunit A,2677,318,1.57 [1.02-2.42],0.0406566289400096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QL2,Complement C1q-like protein 2,2244,268,0.73 [0.55-0.97],0.0310930623897664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2668,319,1.32 [1.10-1.59],0.0030256164397798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,2268,265,0.70 [0.51-0.97],0.0309003474671215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1R,Complement C1r subcomponent,2309,270,0.39 [0.19-0.82],0.0135952214863607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,2666,317,2.85 [1.72-4.72],4.8385846267276245e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,2257,267,2.21 [1.59-3.07],2.2366316281426724e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,2636,313,2.26 [1.76-2.91],2.0519683836943672e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,2676,318,1.44 [1.12-1.85],0.0040382294295386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA2,Carbonic anhydrase 2,2660,320,0.84 [0.73-0.97],0.0152838313428922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,2695,322,1.62 [1.11-2.36],0.0120133371223507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,2676,318,1.56 [1.33-1.84],6.993374036149887e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,2589,310,1.64 [1.21-2.23],0.0015214875032009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,2636,319,1.28 [1.12-1.46],0.0002854230145749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CARHSP1,Calcium-regulated heat-stable protein 1,2589,310,0.76 [0.62-0.93],0.0084565727020085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP10,Caspase-10,2589,310,0.85 [0.74-0.98],0.0258866708095138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLIF,Cobalamin binding intrinsic factor,2656,314,1.24 [1.10-1.40],0.0003519690190365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,2692,319,1.73 [1.34-2.24],2.6026930305677428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL14,C-C motif chemokine 14,2656,316,1.48 [1.19-1.84],0.0004981582744974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,2695,322,1.68 [1.38-2.04],1.370661066284025e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL21,C-C motif chemokine 21,2674,318,1.49 [1.23-1.82],6.619449564206709e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,2692,319,1.74 [1.43-2.12],4.1691963137352016e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL28,C-C motif chemokine 28,2660,320,1.21 [1.04-1.42],0.0147837030959654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN1,CCN family member 1,2634,313,0.87 [0.76-1.00],0.0446230554573664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,2676,318,1.68 [1.34-2.10],6.372235551079593e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,2670,320,1.56 [1.22-2.01],0.0004745988979097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCS,Copper chaperone for superoxide dismutase,2641,320,0.68 [0.55-0.84],0.0004694689696367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCT5,T-complex protein 1 subunit epsilon,2579,308,0.73 [0.57-0.93],0.0114338990495818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD101,Immunoglobulin superfamily member 2,2307,271,1.35 [1.04-1.76],0.0268044207149208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,2670,320,1.33 [1.01-1.76],0.0453540574027032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,2613,310,1.87 [1.48-2.37],1.849788265068006e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,2692,319,1.71 [1.43-2.05],5.748806327496636e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,2668,319,1.38 [1.12-1.71],0.0030319842570912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,2670,320,1.70 [1.27-2.27],0.0003370090673611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD1C,T-cell surface glycoprotein CD1c,2658,318,0.68 [0.48-0.95],0.0249729932307223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,2664,320,1.69 [1.23-2.30],0.0010141854686828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,2588,309,1.45 [1.13-1.85],0.0029615230048433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD248,Endosialin,2316,272,0.73 [0.55-0.96],0.022320107566178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,2658,318,2.30 [1.90-2.79],3.0491488701802097e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,2641,320,1.30 [1.00-1.69],0.0458713669973864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,2663,317,2.54 [1.96-3.28],1.0476081791758597e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,2579,308,1.53 [1.18-1.97],0.001246821093554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,2678,319,1.61 [1.24-2.09],0.0003329347417539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,2668,316,1.39 [1.11-1.73],0.004157320625288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LF,CMRF35-like molecule 1,2676,318,1.27 [1.08-1.49],0.0036361874426516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LG,CMRF35-like molecule 9,2670,320,1.33 [1.04-1.70],0.0242383574889433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,2636,313,1.84 [1.42-2.38],3.7495454769349127e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD4,T-cell surface glycoprotein CD4,2663,320,1.61 [1.20-2.17],0.0016946752343652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,2667,317,1.22 [1.02-1.47],0.0276310981216744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,2644,312,1.66 [1.20-2.29],0.0020446136855151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,2672,317,1.85 [1.33-2.56],0.0002382290840968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,2674,318,1.59 [1.25-2.02],0.0001775629780859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,2569,303,1.66 [1.18-2.34],0.0035023295489002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,2554,303,1.86 [1.29-2.67],0.0009083630066469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,2238,268,1.47 [1.14-1.90],0.0032963828622273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,2678,319,2.23 [1.72-2.90],1.7969371540087395e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2692,319,1.68 [1.38-2.04],2.092284898381435e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,2304,270,1.67 [1.23-2.26],0.0009092909386486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,2664,320,1.40 [1.08-1.82],0.0121112420088157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,2678,319,1.30 [1.08-1.55],0.0044022891413544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,2582,304,1.50 [1.11-2.03],0.0081258431800613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,2670,320,2.13 [1.33-3.41],0.0015556713914757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDA,Cytidine deaminase,2301,270,0.72 [0.56-0.92],0.0098998261784677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,2571,305,2.05 [1.75-2.40],4.79896790198571e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,2673,318,1.17 [1.05-1.30],0.0042290992471527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,2658,316,1.51 [1.34-1.71],1.167770355760415e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,2678,319,1.57 [1.23-2.00],0.0002913800841968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH5,Cadherin-5,2695,322,1.49 [1.09-2.04],0.0115805668079578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH6,Cadherin-6,2658,316,1.34 [1.05-1.72],0.0204561836734132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,2307,271,0.84 [0.73-0.96],0.013319334019037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2664,320,1.14 [1.03-1.27],0.0142364462670454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2555,308,1.19 [1.02-1.40],0.0297465063199132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP85,Centrosomal protein of 85 kDa,2579,308,0.83 [0.71-0.98],0.0269878806952499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,2636,313,1.24 [1.05-1.46],0.0109535347787117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFC1,Cryptic protein,2579,308,1.24 [1.03-1.50],0.0249787994525988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR2,Complement factor H-related protein 2,2294,269,1.32 [1.06-1.66],0.0147610630723042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFP,Properdin,2309,270,0.42 [0.24-0.72],0.0016655534110158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,2670,320,1.41 [1.22-1.62],1.947005034871881e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,2315,273,1.45 [1.05-2.01],0.022721662535699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2658,316,1.62 [1.32-1.98],4.341752392951152e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,2268,265,0.39 [0.31-0.49],1.3939868867124791e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2300,272,1.60 [1.25-2.06],0.0002442260165094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,2316,272,1.17 [1.05-1.29],0.0027385484095047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,2666,317,1.55 [1.25-1.92],5.7193071385443387e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,2600,308,1.18 [1.06-1.32],0.0021633209711142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHL1,Neural cell adhesion molecule L1-like protein,2664,319,1.63 [1.21-2.19],0.0011225391745543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,2672,317,1.72 [1.30-2.29],0.0001588022325611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,2316,272,1.57 [1.26-1.95],5.679297699877354e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,2681,319,2.10 [1.63-2.70],7.361554612875462e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,2316,272,1.28 [1.06-1.54],0.0092747685474803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",2655,317,1.34 [1.15-1.57],0.0002365359716954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLC,Galectin-10,2654,316,1.16 [1.01-1.33],0.0406726307791045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC10A,C-type lectin domain family 10 member A,2641,320,1.36 [1.03-1.78],0.0277025703520253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,2670,320,1.61 [1.22-2.12],0.0007833751263544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,2257,264,0.29 [0.17-0.48],2.301296882663367e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4D,C-type lectin domain family 4 member D,2664,320,1.22 [1.06-1.41],0.0069851312809576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,2653,316,1.42 [1.05-1.91],0.0214443118597362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC6A,C-type lectin domain family 6 member A,2579,308,1.24 [1.02-1.51],0.0302006425862758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,2692,319,1.38 [1.14-1.66],0.0008671839360912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,2676,318,1.92 [1.29-2.85],0.0011964410202563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN1,Calsyntenin-1,2589,310,0.78 [0.63-0.97],0.0278829093155319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN2,Calsyntenin-2,2692,319,1.37 [1.11-1.69],0.0036728486978738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNDP1,Beta-Ala-His dipeptidase,2668,319,1.30 [1.05-1.61],0.0157593656794054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN1,Contactin-1,2695,322,2.02 [1.42-2.87],8.378983729644914e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN2,Contactin-2,2676,318,1.48 [1.20-1.84],0.000256144172046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL15A1,Collagen alpha-1(XV) chain,2316,272,0.45 [0.30-0.67],0.0001043994893517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,2672,319,2.46 [1.69-3.58],2.772615399145492e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL1A1,Collagen alpha-1(I) chain,2695,322,0.39 [0.26-0.60],1.4342312859613834e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,2658,316,1.79 [1.48-2.17],2.3115603584102997e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,2695,322,1.61 [1.27-2.04],6.892262622545516e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,2663,317,1.95 [1.42-2.68],3.9499523713391273e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMP,Cartilage oligomeric matrix protein,2634,315,0.72 [0.54-0.96],0.0239364770340128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,2671,318,1.58 [1.40-1.78],3.935704570992405e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA4,Carboxypeptidase A4,2217,256,0.74 [0.57-0.97],0.0271846041694018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPM,Carboxypeptidase M,2661,315,1.69 [1.30-2.18],6.498198602368511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",2244,268,0.54 [0.34-0.86],0.0088871981694239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPVL,Probable serine carboxypeptidase CPVL,2672,318,1.46 [1.14-1.87],0.0030359623457116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,2304,270,1.61 [1.05-2.46],0.0286442291662441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR2,Complement receptor type 2,2668,319,1.26 [1.04-1.54],0.0194762180345102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,2620,311,0.61 [0.48-0.76],1.978427801067157e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHBP,Corticotropin-releasing factor-binding protein,2663,317,1.56 [1.10-2.21],0.0119578980160356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIM1,Cysteine-rich motor neuron 1 protein,2674,318,2.42 [1.54-3.80],0.0001199864110584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,2295,271,0.44 [0.30-0.66],5.199029776657328e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAC1,Cartilage acidic protein 1,2695,322,0.73 [0.54-0.98],0.0372497205875151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,2641,320,1.36 [1.12-1.65],0.0019118034267888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,2674,318,1.70 [1.21-2.38],0.002218699103076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG5,Chondroitin sulfate proteoglycan 5,2244,266,0.74 [0.57-0.98],0.0333842796025736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,2660,319,1.71 [1.27-2.31],0.0004324038390511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,2316,272,1.68 [1.18-2.41],0.0045233977175928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSB,Cathepsin B,2660,316,1.26 [1.04-1.52],0.020534491789999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,2268,265,1.44 [1.18-1.76],0.0003982482755172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSH,Pro-cathepsin H,2612,315,1.26 [1.10-1.44],0.0008162583789477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,2658,316,1.78 [1.23-2.58],0.0021314284185153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,2692,319,1.80 [1.34-2.40],7.53697672321747e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,2104,233,2.37 [1.45-3.88],0.0006240056328768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,2660,317,1.61 [1.22-2.14],0.0008148081647697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,2262,271,1.32 [1.13-1.54],0.0004584671980285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,2641,320,1.48 [1.13-1.94],0.0048365885597801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXADR,Coxsackievirus and adenovirus receptor,2664,320,1.22 [1.00-1.48],0.0456811674411341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL16,C-X-C motif chemokine 16,2694,322,1.57 [1.06-2.33],0.0254466289966639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL8,Interleukin-8,2631,313,1.14 [1.01-1.29],0.0362735538318334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,2674,318,1.24 [1.07-1.43],0.0037654418293908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTL1,Cytokine-like protein 1,2316,272,0.58 [0.37-0.90],0.0157517971902094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",2636,319,0.86 [0.75-0.99],0.0312239945010497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2658,318,2.39 [1.83-3.10],8.860668455631406e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCC,Netrin receptor DCC,2262,271,0.36 [0.19-0.69],0.0017855470204552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCLRE1C,Protein artemis,2224,264,0.57 [0.37-0.86],0.0077590327599046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,2616,315,2.70 [1.83-3.97],4.832872785403314e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTPP1,dCTP pyrophosphatase 1,2658,316,0.64 [0.46-0.88],0.0062193750766314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,2658,318,0.79 [0.67-0.93],0.0055988788295428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDI2,Protein DDI1 homolog 2,2268,265,0.83 [0.71-0.97],0.01888411642524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDR1,Epithelial discoidin domain-containing receptor 1,2678,319,1.80 [1.22-2.64],0.0027793703778241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDT,D-dopachrome decarboxylase,2316,272,0.71 [0.53-0.94],0.015757246298349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX58,Antiviral innate immune response receptor RIG-I,2579,308,0.81 [0.67-0.98],0.0313368029572873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKZ,Diacylglycerol kinase zeta,2601,309,0.73 [0.55-0.99],0.0415770389745416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK3,Dickkopf-related protein 3,2695,322,1.42 [1.03-1.96],0.0342795643015233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,2636,319,1.69 [1.41-2.04],2.581300228708705e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,2658,318,2.75 [2.10-3.62],3.7654891128636653e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,2243,264,0.52 [0.45-0.61],2.228030304444577e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB2,DnaJ homolog subfamily B member 2,2268,265,0.79 [0.63-0.99],0.0376286046600577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC9,DnaJ homolog subfamily C member 9,2307,271,0.85 [0.72-0.99],0.0368236000363189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,2667,318,0.79 [0.65-0.97],0.0218753117354605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP2,Dipeptidase 2,2636,313,1.40 [1.01-1.93],0.0432819867578541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,2636,313,1.96 [1.54-2.49],4.871144222337933e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,2637,310,2.36 [1.85-3.00],3.1343384796574e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSCAM,Down syndrome cell adhesion molecule,2304,274,1.43 [1.08-1.90],0.0135597548842628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,2670,320,2.38 [1.77-3.20],1.0353036854253261e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,2627,312,0.71 [0.59-0.87],0.0009874824231048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,2636,313,1.53 [1.04-2.24],0.0304508963323335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTYMK,Thymidylate kinase,2304,270,0.83 [0.70-0.99],0.0355111513448945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,2297,268,0.75 [0.57-0.99],0.043894496421605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT3,Dynein light chain Tctex-type 3,2297,268,0.75 [0.57-0.99],0.040384810441461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,2673,318,1.80 [1.32-2.46],0.0001942882149426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2676,318,2.15 [1.76-2.64],1.8338303140073333e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2616,315,1.68 [1.31-2.15],4.147993281396806e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,2243,264,1.95 [1.35-2.83],0.0004229968303981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,2307,271,2.01 [1.43-2.82],5.29267137138028e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2667,319,1.81 [1.36-2.39],3.540547881576567e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,2666,319,2.48 [1.90-3.25],3.126221879304078e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,2637,320,2.72 [2.16-3.43],3.321253310373155e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNB2,Ephrin-B2,2262,271,1.21 [1.02-1.42],0.0254083672463092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFR,Epidermal growth factor receptor,2695,322,2.49 [1.41-4.40],0.0016572998586422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4B,Eukaryotic translation initiation factor 4B,2641,320,0.81 [0.68-0.97],0.0195962635468456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,2658,316,0.83 [0.71-0.97],0.0224057899832702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5A,Eukaryotic translation initiation factor 5A-1,2601,309,0.65 [0.46-0.93],0.0194762175321206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOA,Elongin-A,2636,313,0.82 [0.67-0.99],0.04297207691162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENG,Endoglin,2695,322,1.79 [1.04-3.06],0.03480557821314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO3,Beta-enolase,2243,264,0.69 [0.57-0.84],0.0001914765118298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,2243,264,1.78 [1.29-2.45],0.0004983068193101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTR1,Endosome-associated-trafficking regulator 1,2243,264,0.83 [0.69-1.00],0.0457014154727759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,2553,306,2.43 [1.90-3.11],1.5069163641812173e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,2695,322,2.77 [2.01-3.82],4.89192426630319e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,2636,319,1.37 [1.04-1.81],0.0259409207543481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,2664,320,1.22 [1.09-1.37],0.0007340651402045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2673,318,1.34 [1.00-1.79],0.0498416011327534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,2656,317,1.76 [1.10-2.80],0.018069793867946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,2658,318,2.98 [2.09-4.25],1.4247245501531155e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,2695,322,1.58 [1.20-2.07],0.0009901206232477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXOSC10,Exosome component 10,2242,265,0.65 [0.49-0.87],0.0041857947071182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11,Coagulation factor XI,2282,268,2.03 [1.41-2.91],0.0001403487880527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2,Prothrombin,2309,270,0.39 [0.18-0.85],0.0171915060195908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,2660,318,1.77 [1.26-2.49],0.0010117516684974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",2663,317,1.24 [1.12-1.37],1.6822688609373518e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP2,"Fatty acid-binding protein, intestinal",2658,316,1.19 [1.07-1.34],0.0018369279855089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",2304,270,1.33 [1.11-1.60],0.0025253579845322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",2695,322,1.55 [1.32-1.82],7.946508871745422e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,2636,313,2.06 [1.56-2.73],3.932095558024541e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,2656,314,3.01 [2.29-3.95],2.938192196618076e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,2307,271,1.33 [1.17-1.51],1.889886014914138e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,2690,322,1.53 [1.21-1.93],0.000364033592839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,2670,320,1.27 [1.08-1.50],0.0040095356854033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN2,Ficolin-2,2648,316,0.61 [0.49-0.76],1.42488582535841e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL2,Fc receptor-like protein 2,2683,317,1.27 [1.06-1.52],0.0086996133681624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRLB,Fc receptor-like B,2579,308,1.23 [1.04-1.46],0.0139771956652241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF16,Fibroblast growth factor 16,2244,268,0.75 [0.57-0.98],0.0351786334193655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,2601,309,1.88 [1.46-2.42],7.744424654164005e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,2658,318,0.59 [0.46-0.75],1.493691580333633e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,2316,272,0.60 [0.48-0.75],6.877287778610805e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP3,Fibroblast growth factor-binding protein 3,2300,272,0.51 [0.38-0.69],1.715031783076325e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,2315,273,1.38 [1.17-1.63],0.0001794294337521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIT,Bis(5'-adenosyl)-triphosphatase,2589,310,0.85 [0.73-0.98],0.0215220029828193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2641,320,1.47 [1.05-2.05],0.025741387470182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,2309,270,0.41 [0.27-0.63],4.395665716849109e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,2647,316,1.59 [1.17-2.16],0.0029149797160284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR2,Folate receptor beta,2678,319,1.55 [1.11-2.16],0.0092490411877006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,2243,264,1.50 [1.17-1.91],0.0011661809192031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,2243,264,1.85 [1.11-3.08],0.0178793144985708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,2660,316,1.86 [1.44-2.41],2.172280997778154e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FTCD,Formimidoyltransferase-cyclodeaminase,2296,271,0.88 [0.78-0.99],0.0295911060777393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUOM,Fucose mutarotase,2268,265,0.78 [0.65-0.92],0.0039277663975284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,2658,318,0.69 [0.52-0.90],0.0064574680073277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUS,RNA-binding protein FUS,2571,308,0.73 [0.55-0.96],0.0239851378689342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2601,309,1.56 [1.26-1.94],5.0798599515296446e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT7,N-acetylgalactosaminyltransferase 7,2636,313,2.31 [1.43-3.74],0.0005892441727296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS2,Growth arrest-specific protein 2,2271,266,0.72 [0.55-0.94],0.0165831283359717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS6,Growth arrest-specific protein 6,2680,320,1.85 [1.26-2.72],0.001637591447525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GASK1A,Golgi-associated kinase 1A,2242,265,0.71 [0.55-0.93],0.0122925093526621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAST,Gastrin,2300,272,1.10 [1.03-1.18],0.0072671627326094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,2224,264,0.63 [0.40-1.00],0.048589221295752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP1,Guanylate-binding protein 1,2296,271,0.82 [0.70-0.97],0.0208056708324163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,2579,308,1.19 [1.10-1.29],1.0024460358538072e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2636,313,1.79 [1.35-2.36],4.463763247012501e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,2695,322,2.17 [1.91-2.46],6.232915200798986e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,2673,318,2.57 [1.91-3.45],3.5024341422154517e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,2636,318,1.51 [1.08-2.11],0.017219783628975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,2641,320,2.52 [1.77-3.59],2.967836807375607e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,2656,314,1.10 [1.04-1.16],0.0007586501007312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,2268,265,0.41 [0.28-0.60],5.423948720304702e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GID8,Glucose-induced degradation protein 8 homolog,2304,274,1.34 [1.05-1.71],0.018780920446759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,2243,264,1.40 [1.14-1.72],0.0011309582342006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,2300,272,1.51 [1.08-2.12],0.0171902581454979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GKN1,Gastrokine-1,2545,302,1.52 [1.04-2.22],0.0310934819837673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLOD4,Glyoxalase domain-containing protein 4,2660,317,0.68 [0.51-0.91],0.0098156373621055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,2268,265,1.38 [1.03-1.84],0.0307460289547958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR,GMP reductase 1,2692,319,0.75 [0.61-0.91],0.0038974815788926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,2579,308,0.80 [0.68-0.94],0.0081727909791544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNLY,Granulysin,2670,320,0.81 [0.70-0.95],0.0091382882529431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,2268,265,0.61 [0.44-0.83],0.0020278088981671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLM2,Protein GOLM2,2678,319,1.37 [1.01-1.85],0.0403004454777515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOT1,"Aspartate aminotransferase, cytoplasmic",2316,272,0.57 [0.44-0.75],3.4723736956009936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,2585,312,1.15 [1.05-1.27],0.0039823407410406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,2636,313,0.89 [0.82-0.96],0.0024090413772755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,2676,318,1.49 [1.09-2.05],0.0130024596876687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,2595,307,2.40 [1.72-3.35],2.519656776027049e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,2616,315,1.17 [1.00-1.36],0.0474858923101166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPRC5C,G-protein coupled receptor family C group 5 member C,2297,268,1.26 [1.05-1.52],0.0154886491259106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,2655,319,2.69 [1.87-3.86],8.02253871504669e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSN,Gelsolin,2308,273,0.57 [0.36-0.91],0.0174702180228172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSR,"Glutathione reductase, mitochondrial",2303,271,0.56 [0.39-0.80],0.0016292660389497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,2654,316,0.83 [0.74-0.92],0.0007138086669191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA3,Glutathione S-transferase A3,2579,308,0.82 [0.73-0.93],0.0017610747850596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,2658,320,1.65 [1.30-2.10],4.238411350948048e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUSB,Beta-glucuronidase,2676,320,0.86 [0.74-0.99],0.0359957658006364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GYS1,"Glycogen [starch] synthase, muscle",2616,315,0.85 [0.76-0.95],0.0040225103898449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMB,Granzyme B,2664,320,0.78 [0.66-0.93],0.0046486361016469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",2671,318,0.85 [0.74-0.97],0.0193561530089525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,2674,318,1.70 [1.52-1.89],1.0162301859408154e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,2670,320,1.80 [1.40-2.32],4.831901445607022e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBQ1,Hemoglobin subunit theta-1,2676,318,0.85 [0.72-1.00],0.0477833267293486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCLS1,Hematopoietic lineage cell-specific protein,2692,319,0.80 [0.66-0.96],0.0149607217198119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,2304,270,3.55 [2.27-5.55],2.7357524963720563e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGFAC,Hepatocyte growth factor activator,2295,270,1.60 [1.03-2.50],0.0364026859964161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",2655,319,1.42 [1.10-1.82],0.0064059459649847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2664,320,1.60 [1.21-2.13],0.0011020902985101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMBS,Porphobilinogen deaminase,2676,318,0.69 [0.54-0.87],0.0018211328113093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX1,Heme oxygenase 1,2636,313,0.80 [0.66-0.98],0.034609981403028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,2676,318,1.39 [1.12-1.74],0.0034690651244153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2642,314,1.53 [1.12-2.09],0.0073446328194956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYAL1,Hyaluronidase-1,2641,313,2.08 [1.43-3.04],0.000144220797937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,2695,322,1.74 [1.18-2.56],0.0051023638812679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,2695,322,1.68 [1.23-2.27],0.0009262603802319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM3,Intercellular adhesion molecule 3,2695,322,1.86 [1.34-2.59],0.0002383010182861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,2674,318,1.83 [1.20-2.79],0.0053374481372387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,2636,313,2.05 [1.40-2.99],0.0002213613896687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,2692,321,1.14 [1.05-1.23],0.0011743740307473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,2690,322,1.39 [1.20-1.60],6.910835270626098e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,2668,319,0.67 [0.53-0.84],0.0004064670784292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,2640,315,1.68 [1.42-2.00],2.873784525771541e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,2651,315,1.55 [1.19-2.01],0.001032898141571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP7,Insulin-like growth factor-binding protein 7,2695,322,1.68 [1.33-2.13],1.737553134711918e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,2658,316,1.30 [1.01-1.66],0.0381171852781059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF3,Immunoglobulin superfamily member 3,2636,313,1.30 [1.05-1.61],0.0158204662113542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,2658,316,1.51 [1.16-1.98],0.0025856212173339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,2674,318,1.76 [1.29-2.40],0.0003556916313576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,2601,309,1.40 [1.08-1.81],0.0120407077517998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,2664,320,1.93 [1.46-2.54],3.163717228115936e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,2601,309,1.38 [1.06-1.81],0.0177173678611308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,2601,309,1.36 [1.22-1.52],5.991402895162653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,2637,317,1.31 [1.09-1.57],0.0035078927348017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,2668,319,1.97 [1.50-2.58],9.979822399887471e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,2692,319,1.77 [1.36-2.32],2.987106102248664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18RAP,Interleukin-18 receptor accessory protein,2626,317,0.93 [0.87-0.99],0.0216062373792992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,2601,312,1.17 [1.04-1.32],0.0088111491964026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,2666,319,4.83 [3.50-6.67],8.835571952618715e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,2690,322,1.49 [1.19-1.87],0.0004849974086347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,2643,315,1.67 [1.34-2.07],4.198189311505583e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RG,Cytokine receptor common subunit gamma,2297,268,1.53 [1.12-2.07],0.0069072860074767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,2664,320,1.92 [1.51-2.45],1.360812706114408e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5RA,Interleukin-5 receptor subunit alpha,2664,320,1.22 [1.04-1.44],0.0177392020326205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6ST,Interleukin-6 receptor subunit beta,2658,316,2.81 [1.65-4.78],0.0001329608584648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPACT,Protein IMPACT,2300,272,0.77 [0.62-0.96],0.0173781517792519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",2304,274,0.69 [0.49-0.97],0.0325411973504133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,2297,268,1.48 [1.20-1.83],0.0003078876506418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL5,Insulin-like peptide INSL5,2307,271,1.13 [1.01-1.27],0.0276443389896286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSR,Insulin receptor,2244,268,3.30 [1.76-6.18],0.0001928332353809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM2,Isthmin-2,2316,272,1.28 [1.05-1.56],0.013697112581048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA6,Integrin alpha-6,2664,320,0.80 [0.65-0.99],0.0381038872874139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAM,Integrin alpha-M,2670,320,1.51 [1.14-2.00],0.0037297437800126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,2660,317,1.92 [1.42-2.59],1.965266522971349e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,2601,309,2.22 [1.62-3.04],7.966030745185531e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,2676,318,1.43 [1.18-1.74],0.0002504152629722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGBL1,Integrin beta-like protein 1,2316,272,1.28 [1.02-1.60],0.0313068212138805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2668,319,1.94 [1.51-2.50],2.57546747607015e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,2678,319,2.69 [2.00-3.63],8.525324509003742e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,2658,316,1.38 [1.08-1.75],0.0089368849239505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,2589,310,1.23 [1.08-1.40],0.0015925718811731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,2631,315,1.98 [1.47-2.66],5.906451179370649e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,2676,318,1.60 [1.42-1.81],3.7646573913166174e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK7,Kallikrein-7,2210,256,0.72 [0.52-0.98],0.0373072983761266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2692,319,2.47 [1.98-3.07],4.640707934703188e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,2692,319,1.39 [1.14-1.71],0.0014966493460869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,2300,272,1.39 [1.07-1.80],0.0126935914981231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",2661,320,1.59 [1.41-1.80],1.4970607237672296e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,2657,316,0.75 [0.63-0.89],0.001321609750003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,2692,319,0.74 [0.61-0.90],0.0027868807971078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACTB2,Endoribonuclease LACTB2,2658,316,0.85 [0.73-1.00],0.0456373493699218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,2636,313,1.66 [1.39-1.97],1.545208351947739e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2663,317,1.72 [1.43-2.06],5.068952698420438e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMB1,Laminin subunit beta-1,2243,264,1.62 [1.12-2.34],0.0105598174745885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMTOR5,Ragulator complex protein LAMTOR5,2297,268,0.68 [0.49-0.94],0.0192968446091032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,2636,319,2.22 [1.81-2.73],1.8541749064802954e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBP,Lipopolysaccharide-binding protein,2668,319,1.23 [1.04-1.46],0.0163456946385764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,2304,274,1.33 [1.17-1.51],1.075288649014996e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,2581,310,1.42 [1.14-1.76],0.001745574662406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCP1,Plastin-2,2316,272,0.59 [0.45-0.77],9.210900580664952e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLR,Low-density lipoprotein receptor,2671,320,0.76 [0.63-0.91],0.0036000092302004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,2658,316,1.66 [1.24-2.22],0.0006548293018954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,2665,318,1.84 [1.34-2.52],0.0001728083693185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,2663,317,1.73 [1.50-2.00],1.5827829125595034e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,2667,317,1.37 [1.00-1.86],0.0472552824884774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2660,317,0.76 [0.64-0.89],0.0008349068399326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,2664,320,4.59 [3.27-6.44],1.1423188806697368e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2656,314,1.39 [1.02-1.88],0.035226936920716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,2685,322,1.60 [1.21-2.13],0.0010581843917547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2601,309,1.25 [1.00-1.56],0.0481670325057847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIPF,Gastric triacylglycerol lipase,2243,264,1.19 [1.01-1.40],0.0409584834731436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,2304,274,1.71 [1.31-2.22],6.443403314679949e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,2575,314,1.46 [1.26-1.70],3.5251330974416097e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2671,318,1.51 [1.16-1.96],0.002335019109421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,2658,316,1.45 [1.13-1.86],0.0038593420962747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,2304,274,0.57 [0.36-0.90],0.0169418877692103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2695,322,2.18 [1.67-2.85],1.2118084484134446e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,2579,308,1.20 [1.03-1.40],0.0164028076761706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,2651,317,1.45 [1.07-1.96],0.0169101843564259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LXN,Latexin,2628,320,0.85 [0.74-0.99],0.0363353280251729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,2623,312,1.71 [1.25-2.33],0.0006971779464298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD3,Ly6/PLAUR domain-containing protein 3,2636,315,1.49 [1.14-1.96],0.0039202842242116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,2579,308,1.19 [1.05-1.35],0.0056974613198767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,2262,271,0.87 [0.76-0.98],0.0285134292711057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAEA,E3 ubiquitin-protein transferase MAEA,2579,308,0.73 [0.55-0.97],0.0280384895458663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGEA3,Melanoma-associated antigen 3,2271,266,1.29 [1.12-1.49],0.0004729222243609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,2304,270,1.65 [1.23-2.22],0.0008068210873591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC1,MANSC domain-containing protein 1,2658,318,1.46 [1.04-2.06],0.0279134002232751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN3,Matrilin-3,2637,320,0.71 [0.53-0.94],0.0177589895512566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,2668,319,1.88 [1.46-2.43],1.0230423109090268e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDH1,"Malate dehydrogenase, cytoplasmic",2301,272,0.70 [0.51-0.94],0.0199037091423226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,2649,317,1.51 [1.28-1.77],4.5658265450279163e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,2663,317,0.44 [0.31-0.63],7.817820678440934e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MET,Hepatocyte growth factor receptor,2676,320,1.71 [1.07-2.75],0.0263486410094948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3L,Microfibrillar-associated protein 3-like,2262,271,0.76 [0.59-0.96],0.0224156787096508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,2268,265,1.70 [1.21-2.39],0.0022018926165993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,2670,320,1.23 [1.01-1.49],0.0420282197152433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2664,320,1.09 [1.01-1.17],0.0222497497277438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIF,Macrophage migration inhibitory factor,2664,318,0.83 [0.72-0.97],0.0173502292359583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MILR1,Allergin-1,2601,309,1.30 [1.07-1.57],0.0071206311264111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLN,Promotilin,2664,320,1.14 [1.02-1.28],0.0232235764751338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,2583,310,1.22 [1.09-1.37],0.0004853452346564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,2657,316,1.42 [1.22-1.66],8.656811883731802e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,2660,318,1.37 [1.16-1.63],0.0002305978458464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP15,Matrix metalloproteinase-15,2304,270,1.21 [1.01-1.45],0.0394404986387128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,2670,320,1.24 [1.04-1.49],0.0197127441833786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,2613,315,1.73 [1.41-2.13],1.3649290964318853e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L1,Mortality factor 4-like protein 1,2271,266,0.70 [0.50-1.00],0.0476345391227903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPRIP,Myosin phosphatase Rho-interacting protein,2293,268,0.74 [0.56-0.98],0.0359970765844414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,2315,273,1.76 [1.19-2.59],0.004403885630445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL46,"39S ribosomal protein L46, mitochondrial",2589,310,0.66 [0.45-0.98],0.0376397812823594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSMB,Beta-microseminoprotein,2663,318,1.15 [1.00-1.31],0.0460499234099274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,2678,319,1.49 [1.21-1.83],0.0001388639375768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,2589,310,1.71 [1.48-1.97],2.995969199890602e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZT1,Mitotic-spindle organizing protein 1,2579,308,0.78 [0.63-0.97],0.0243520677460392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGK,N-acetyl-D-glucosamine kinase,2240,264,0.74 [0.60-0.91],0.0046525218075134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2658,318,2.11 [1.54-2.90],3.894337940999061e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,2678,319,0.51 [0.40-0.65],2.48997219815474e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,2661,320,1.91 [1.51-2.42],9.047378940225512e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2307,271,1.81 [1.33-2.44],0.0001291737367761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,2676,318,1.68 [1.22-2.32],0.0015992502477435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,2656,314,2.10 [1.59-2.76],1.1789996198949197e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,2658,318,1.92 [1.53-2.40],1.496918486923398e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,2581,309,1.89 [1.61-2.22],6.6218801511156e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,2658,318,0.60 [0.49-0.74],9.736683809088388e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,2692,319,2.89 [2.18-3.85],2.435073654945355e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGF,Beta-nerve growth factor,2641,320,2.32 [1.08-4.99],0.0316543419722344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT1,Deaminated glutathione amidase,2243,264,0.68 [0.52-0.88],0.0035590844090621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,2695,322,4.73 [2.69-8.34],7.29602397829323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH3,Neurogenic locus notch homolog protein 3,2695,322,1.33 [1.01-1.75],0.0396487587118414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,2281,267,1.85 [1.32-2.58],0.0003033545649026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,2658,316,1.47 [1.14-1.90],0.0032213389407367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPB,Natriuretic peptides B,2616,315,1.10 [1.03-1.18],0.0041246358082754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX1,Neuronal pentraxin-1,2670,320,1.26 [1.02-1.57],0.031851976744603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,2676,318,1.21 [1.04-1.40],0.0149863225739099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,2658,316,2.21 [1.66-2.94],5.003778551865256e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,2671,320,2.15 [1.52-3.03],1.3750974096368526e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NSFL1C,NSFL1 cofactor p47,2678,319,0.84 [0.72-0.99],0.0337675054853008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF3,Neurotrophin-3,2664,320,1.31 [1.02-1.68],0.0344867418186785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,2658,316,1.14 [1.05-1.22],0.0007314114415458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH1,Neurexophilin-1,2589,310,0.72 [0.55-0.94],0.0163483853286907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,2670,320,1.46 [1.19-1.78],0.0002610163269982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMD,Osteomodulin,2674,318,0.60 [0.49-0.75],2.3137422803287306e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,2636,313,0.80 [0.69-0.92],0.0013641624142119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSBPL2,Oxysterol-binding protein-related protein 2,2300,272,0.60 [0.40-0.90],0.0142149568849846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSMR,Oncostatin-M-specific receptor subunit beta,2671,320,2.04 [1.28-3.25],0.0026407250794298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI4,Protein-arginine deiminase type-4,2583,309,0.84 [0.73-0.97],0.0161976199792352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAPPA,Pappalysin-1,2601,309,0.67 [0.54-0.83],0.0003695077650171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBLD,Phenazine biosynthesis-like domain-containing protein,2589,310,0.76 [0.63-0.91],0.0037262462546439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,2263,264,0.72 [0.57-0.89],0.0030109770382767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH1,Protocadherin-1,2678,319,1.76 [1.14-2.70],0.0107001149011699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH12,Protocadherin-12,2304,274,1.56 [1.03-2.36],0.0376083465780709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,2658,316,1.41 [1.12-1.77],0.0036278666738726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,2307,271,1.71 [1.30-2.25],0.0001365969488461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH9,Protocadherin-9,2307,271,0.67 [0.49-0.93],0.0155155956904724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,2695,322,1.33 [1.05-1.69],0.020265643883496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,2673,318,1.33 [1.07-1.65],0.0106315107014184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,2636,313,2.32 [1.79-3.01],2.552252875408677e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,2658,316,1.76 [1.28-2.42],0.0005251015892027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEAR1,Platelet endothelial aggregation receptor 1,2695,322,1.88 [1.23-2.88],0.0037743093499251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEPD,Xaa-Pro dipeptidase,2315,273,0.50 [0.34-0.73],0.0003990738665787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PER3,Period circadian protein homolog 3,2244,268,0.89 [0.81-0.98],0.0203355666648198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,2692,319,1.90 [1.36-2.65],0.0001799290176927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,2627,316,1.25 [1.07-1.46],0.003870480250271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,2630,313,1.76 [1.40-2.20],1.1091536683369543e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,2664,320,0.80 [0.68-0.95],0.0096459233872762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2670,320,2.66 [2.05-3.45],1.8383582618865472e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,2670,320,1.69 [1.34-2.13],7.203141542417653e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,2658,316,1.38 [1.15-1.66],0.0005083726193733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,2268,265,0.84 [0.71-0.99],0.0353818410023136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,2304,270,2.56 [1.72-3.83],4.258367741740331e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,2641,320,1.56 [1.31-1.85],4.2053851133198454e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,2670,320,0.44 [0.35-0.55],5.414098897931027e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,2690,322,0.71 [0.59-0.84],0.0001008983986441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,2651,317,1.74 [1.25-2.42],0.0010090481325961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",2300,272,0.71 [0.58-0.87],0.0008083462633825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLPBP,Pyridoxal phosphate homeostasis protein,2658,316,0.82 [0.70-0.95],0.0096268009483043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,2686,320,3.70 [2.82-4.86],4.9324503865200675e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,2244,268,1.58 [1.27-1.96],3.235194147279368e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON1,Serum paraoxonase/arylesterase 1,2315,273,0.57 [0.38-0.84],0.0048984591999724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,2678,319,0.73 [0.59-0.91],0.0049478209176289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPME1,Protein phosphatase methylesterase 1,2636,313,0.84 [0.71-0.99],0.0350208748052716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2304,274,1.52 [1.19-1.93],0.0006343278003102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,2645,313,1.22 [1.11-1.33],1.683317317930855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,2316,272,1.77 [1.29-2.44],0.0004297968210225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,2679,320,1.78 [1.37-2.30],1.5437421458175527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX2,Peroxiredoxin-2,2282,271,0.77 [0.64-0.94],0.0092248151490347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX6,Peroxiredoxin-6,2676,318,0.84 [0.71-0.99],0.0333892699771776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,2663,317,1.56 [1.03-2.37],0.0365791745450451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRL,Prolactin,2678,319,1.13 [1.00-1.29],0.0476235770574298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS22,Brain-specific serine protease 4,2244,268,1.41 [1.05-1.89],0.0206122439119428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,2653,316,1.69 [1.34-2.14],1.224465505353844e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS53,Serine protease 53,2300,272,0.60 [0.46-0.79],0.0002031929321208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,2652,317,1.85 [1.47-2.33],1.2720920800357638e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTG,Protogenin,2676,318,1.60 [1.08-2.37],0.0191857060966029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,2300,271,1.85 [1.24-2.76],0.002772220544559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,2641,320,1.20 [1.09-1.32],0.000177642817812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,2636,313,0.80 [0.66-0.96],0.0160200757712239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME1,Proteasome activator complex subunit 1,2639,320,0.71 [0.54-0.94],0.0183127797801488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG3,Proteasome assembly chaperone 3,2664,320,0.74 [0.61-0.91],0.0038701705066015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSPN,Persephin,2664,320,1.14 [1.03-1.27],0.0129529319957128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,2639,314,1.74 [1.36-2.23],9.876376952373976e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH,Parathyroid hormone,2262,271,0.84 [0.74-0.96],0.0126928239277394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2664,320,1.23 [1.00-1.50],0.0467050621847297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,2589,310,1.37 [1.05-1.79],0.0186095521315036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,2304,270,1.77 [1.23-2.56],0.0021270688049845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,2695,322,1.57 [1.13-2.19],0.0076439637155918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,2307,271,1.35 [1.10-1.67],0.0044123450877153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2631,318,1.38 [1.06-1.80],0.0179184262869477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,2268,265,0.80 [0.65-0.98],0.0314744400667926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,2579,307,0.81 [0.69-0.96],0.0143443964306376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,2664,320,1.24 [1.00-1.54],0.0480927241223397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVR,Poliovirus receptor,2678,319,1.51 [1.21-1.88],0.0002814198356728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,2242,265,1.35 [1.23-1.48],6.576085861558403e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QDPR,Dihydropteridine reductase,2647,316,0.69 [0.54-0.88],0.0031250241664441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,2667,320,2.14 [1.50-3.07],3.2236239045661745e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,2664,320,0.72 [0.58-0.89],0.0021633993610363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABGAP1L,Rab GTPase-activating protein 1-like,2601,309,0.84 [0.70-1.00],0.0452719508191328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,2579,308,1.54 [1.15-2.06],0.0041318575978228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,2304,274,1.74 [1.33-2.27],4.996350554412822e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBKS,Ribokinase,2603,318,0.67 [0.58-0.76],1.4770629871403743e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,2636,313,1.25 [1.12-1.40],0.0001150845240051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,2642,315,2.00 [1.72-2.33],4.349247353812957e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,2695,322,1.62 [1.40-1.87],1.2458868493885095e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,2695,322,1.46 [1.28-1.67],3.4892515214940064e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,2668,317,2.07 [1.78-2.40],1.3474796756271365e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,2670,320,1.38 [1.02-1.86],0.0395834152231621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,2658,316,1.47 [1.34-1.60],1.5941851246165485e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,2271,266,1.27 [1.09-1.49],0.0021066815097944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,2678,319,1.59 [1.19-2.13],0.0015513947303296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,2678,319,1.49 [1.08-2.05],0.0139678828934256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILP,Rab-interacting lysosomal protein,2671,318,0.84 [0.71-0.98],0.0292755953409283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN1,Prorelaxin H1,2304,274,1.30 [1.05-1.61],0.013978225700283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,2315,273,1.82 [1.22-2.71],0.0034896367414964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE10,Inactive ribonuclease-like protein 10,2243,264,1.30 [1.03-1.63],0.0249851019549222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,2297,270,1.56 [1.26-1.94],4.842531749205959e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,2687,322,2.28 [1.64-3.18],1.0666711986277435e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,2243,264,2.22 [1.59-3.12],3.5245312360580286e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF5,E3 ubiquitin-protein ligase RNF5,2243,264,0.84 [0.72-0.99],0.0380899289204056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2658,316,1.40 [1.05-1.85],0.019769236968939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,2676,318,1.70 [1.24-2.33],0.0009691898558691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,2676,318,2.00 [1.53-2.62],3.948880303302855e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A14,Protein S100-A14,2304,274,0.76 [0.60-0.97],0.026314578454072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A16,Protein S100-A16,2583,309,0.83 [0.69-0.99],0.0334245041070187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A4,Protein S100-A4,2658,318,0.83 [0.70-0.99],0.0391702824854703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100G,Protein S100-G,2304,274,0.71 [0.56-0.91],0.0066369009083426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,2616,315,1.25 [1.09-1.43],0.0015900488243417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAA4,Serum amyloid A-4 protein,2309,270,0.39 [0.20-0.76],0.0056369417621161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,2678,319,2.65 [1.99-3.52],1.8347540931806405e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,2591,318,1.97 [1.55-2.52],4.568085765837818e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,2678,319,2.23 [1.68-2.95],2.6145691189291736e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,2667,318,2.48 [1.93-3.20],2.2521159896677997e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,2601,309,1.74 [1.47-2.05],6.389190327484939e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCLY,Selenocysteine lyase,2671,318,0.82 [0.67-0.99],0.0381854762832298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN4B,Sodium channel subunit beta-4,2243,264,1.35 [1.06-1.72],0.0158435636943987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCT,Secretin,2262,271,1.50 [1.20-1.86],0.0002769712206447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC4,Syndecan-4,2658,316,0.75 [0.62-0.91],0.0042109528658339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,2243,264,1.52 [1.09-2.12],0.0133356694039352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELE,E-selectin,2695,322,1.35 [1.13-1.61],0.0009055669856637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELL,L-selectin,2309,270,0.55 [0.33-0.92],0.0235095298213803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3F,Semaphorin-3F,2658,316,1.54 [1.09-2.18],0.0135684933927946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,2690,322,2.04 [1.55-2.68],4.345865394795571e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA6,Corticosteroid-binding globulin,2309,270,2.47 [1.22-5.03],0.0124960075222571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINC1,Antithrombin-III,2304,270,2.15 [1.00-4.61],0.048706826681616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,2633,319,0.55 [0.39-0.78],0.0006843013450537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,2658,318,1.56 [1.12-2.18],0.0091905463399075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SF3B4,Splicing factor 3B subunit 4,2636,313,0.84 [0.73-0.97],0.0184057717319252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA1,Pulmonary surfactant-associated protein A1,2579,308,1.20 [1.02-1.40],0.0291616698871794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GL3,Endophilin-A3,2260,266,1.17 [1.02-1.35],0.0261429543286933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,2316,272,1.50 [1.04-2.15],0.0310142548449765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,2674,318,1.55 [1.23-1.96],0.0002061177336708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,2664,320,1.66 [1.28-2.14],0.000106229784253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,2676,318,2.51 [1.88-3.36],4.89780018959486e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,2658,316,1.65 [1.18-2.32],0.003810267347647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,2656,317,1.56 [1.28-1.90],9.319725416570253e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,2601,309,1.43 [1.20-1.71],5.495714922190227e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,2664,320,1.32 [1.12-1.55],0.000765845597872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,2579,308,1.25 [1.03-1.51],0.0219788135869206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,2589,310,1.31 [1.03-1.67],0.0262235770716008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",2224,264,1.23 [1.03-1.48],0.0227035523835024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK1,SLIT and NTRK-like protein 1,2244,268,0.63 [0.44-0.89],0.0097843466717699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,2676,318,1.50 [1.19-1.90],0.0005968047521017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,2616,315,1.65 [1.32-2.07],1.3864897924597037e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,2636,313,0.56 [0.34-0.91],0.0198744897017071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,2674,318,1.57 [1.24-1.97],0.0001527995673013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,2297,268,0.81 [0.67-0.98],0.0318525338291659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAPIN,SNARE-associated protein Snapin,2304,274,0.75 [0.62-0.92],0.0055361009186985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCA,Alpha-synuclein,2268,265,0.85 [0.76-0.93],0.0009756458827689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,2641,320,1.30 [1.12-1.51],0.0005302008475384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",2243,264,1.58 [1.11-2.25],0.010676465183728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX15,Sorting nexin-15,2268,265,0.75 [0.60-0.93],0.0103509686575344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",2670,320,0.79 [0.62-0.99],0.0430252607421824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,2579,308,1.39 [1.08-1.78],0.0096037440709214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORD,Sorbitol dehydrogenase,2665,317,0.78 [0.69-0.88],0.0001050437824553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,2670,320,2.13 [1.80-2.53],3.456071292712457e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK2,Serine protease inhibitor Kazal-type 2,2268,265,1.36 [1.02-1.81],0.033769837833765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,2664,320,1.73 [1.53-1.96],1.6521183398283761e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,2674,318,1.62 [1.28-2.04],5.348716478557378e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,2641,320,0.42 [0.30-0.60],1.3983342362394305e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,2668,317,2.07 [1.60-2.68],3.008084562388505e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,2645,312,1.73 [1.32-2.26],6.937306677702747e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2656,314,0.91 [0.84-0.98],0.0090905328923264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST13,Hsc70-interacting protein,2268,265,0.74 [0.60-0.92],0.0064287654625083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2636,313,1.52 [1.29-1.80],7.502976238130345e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT5B,Signal transducer and activator of transcription 5B,2636,313,0.93 [0.86-1.00],0.0435808516579396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC1,Stanniocalcin-1,2678,319,1.24 [1.02-1.51],0.0349530448628144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC2,Stanniocalcin-2,2666,320,1.54 [1.03-2.30],0.0374966754925455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,2670,320,1.72 [1.24-2.37],0.0010892131104111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYAP1,Synapse-associated protein 1,2268,265,0.80 [0.65-0.99],0.0393581957981473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,2336,276,2.46 [1.77-3.43],1.0384990485492233e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,2636,313,1.48 [1.17-1.87],0.0010470167233674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1A,T-cell leukemia/lymphoma protein 1A,2640,319,0.85 [0.77-0.94],0.0008672748622343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,2690,322,2.38 [1.76-3.22],2.0289735829500583e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEK,Angiopoietin-1 receptor,2658,318,1.60 [1.06-2.42],0.0257761067098864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,2657,319,1.40 [1.27-1.54],2.899610156468427e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,2672,317,1.61 [1.40-1.85],1.6251812398022542e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,2649,318,1.76 [1.50-2.07],2.585707090143091e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFRC,Transferrin receptor protein 1,2668,320,1.30 [1.02-1.66],0.033057101329584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,2664,320,1.31 [1.08-1.59],0.0061472567421818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,2646,316,0.65 [0.46-0.92],0.0161678000568254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,2658,318,1.87 [1.51-2.32],1.3417871321168985e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,2650,314,0.87 [0.77-1.00],0.0433208025117212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,2315,273,1.82 [1.21-2.71],0.0036993786680062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,2658,316,1.62 [1.21-2.18],0.0011602746795314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS2,Thrombospondin-2,2670,320,1.27 [1.03-1.55],0.0225614439093131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THOP1,Thimet oligopeptidase,2649,314,0.58 [0.43-0.78],0.0002873580794852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THY1,Thy-1 membrane glycoprotein,2678,319,1.48 [1.08-2.04],0.0147075996955672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIE1,Tyrosine-protein kinase receptor Tie-1,2695,322,1.36 [1.05-1.77],0.0213337487908261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,2668,319,0.73 [0.58-0.91],0.0046038764509676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP1,Metalloproteinase inhibitor 1,2626,314,1.89 [1.41-2.55],2.5897611927804204e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TINAGL1,Tubulointerstitial nephritis antigen-like,2652,314,2.03 [1.33-3.10],0.0011227630889926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,2636,313,1.35 [1.21-1.51],4.9607425159403086e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,2614,315,1.29 [1.03-1.63],0.0284897331742756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2641,320,1.75 [1.40-2.19],8.47366455030315e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2641,320,1.38 [1.21-1.57],2.105787497288551e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2692,319,2.02 [1.65-2.47],6.4200237102900594e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2663,317,1.66 [1.23-2.24],0.0008806506724308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2658,318,1.89 [1.48-2.42],3.1649987278613945e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2668,317,1.56 [1.22-1.99],0.0003511027586706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2601,309,1.35 [1.09-1.67],0.0061546661324073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2668,317,2.06 [1.60-2.65],2.148923356749332e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2676,318,1.57 [1.24-2.00],0.0002135523063158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2670,320,2.46 [1.90-3.17],7.01346362319154e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2670,320,1.44 [1.22-1.69],1.243062567367112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2678,319,1.80 [1.30-2.48],0.0003799815088312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2686,319,1.96 [1.57-2.44],2.3296914259488317e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2641,320,1.23 [1.05-1.45],0.0124572240937149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2678,319,1.30 [1.05-1.60],0.0155372601543538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2641,320,1.49 [1.23-1.80],3.104393028214851e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,2664,320,0.79 [0.67-0.94],0.0060365637641072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,2692,319,0.59 [0.41-0.83],0.0028621435808409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2674,318,2.11 [1.50-2.95],1.5170945740192528e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNNI3,"Troponin I, cardiac muscle",2616,315,0.89 [0.80-0.99],0.0340351660011703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNXB,Tenascin-X,2670,320,0.50 [0.35-0.70],8.307219195540958e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53I3,Quinone oxidoreductase PIG3,2216,259,0.73 [0.57-0.92],0.0077819098110075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPK1,Thiamin pyrophosphokinase 1,2304,270,0.34 [0.23-0.51],1.3718055174055876e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPMT,Thiopurine S-methyltransferase,2579,308,0.85 [0.73-0.98],0.0305483245461567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPP1,Tripeptidyl-peptidase 1,2644,316,1.37 [1.14-1.66],0.0010870552530652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSAB1,Tryptase alpha/beta-1,2688,319,1.26 [1.03-1.55],0.0246704803394467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF2,TNF receptor-associated factor 2,2664,320,0.86 [0.74-1.00],0.0438197867755718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,2664,320,0.87 [0.76-1.00],0.0469199586627099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,2658,316,0.83 [0.72-0.96],0.0121153748312634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2244,268,1.37 [1.13-1.65],0.0012106371929945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,2641,320,1.50 [1.19-1.89],0.0005991875263951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,2687,320,0.84 [0.71-1.00],0.0483090475682586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,2300,272,1.36 [1.02-1.82],0.0340474647199203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,2620,313,1.94 [1.39-2.72],0.0001044520019233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,2666,317,2.16 [1.58-2.96],1.5956036012523776e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,2686,318,1.74 [1.38-2.20],3.6553606694625305e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VMO1,Vitelline membrane outer layer protein 1 homolog,2636,313,1.19 [1.02-1.39],0.0282814801181292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2297,268,1.44 [1.25-1.66],4.587993996261711e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2666,320,1.96 [1.58-2.41],4.798559041273039e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,2300,272,0.67 [0.50-0.89],0.0068041510175977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,2616,315,1.28 [1.10-1.50],0.0019077022574176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,2579,308,1.43 [1.09-1.86],0.0088790777554116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,2632,319,1.39 [1.11-1.74],0.0047586232062924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,2523,292,1.80 [1.47-2.21],1.7249140297573675e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,2676,318,0.52 [0.39-0.70],1.0973266386430263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,2601,309,2.06 [1.57-2.72],2.623691735337515e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,2641,320,0.80 [0.66-0.98],0.0271398715808707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,2676,318,1.25 [1.07-1.47],0.0046951966769939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,2681,322,1.63 [1.25-2.13],0.0002938761717677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XPNPEP2,Xaa-Pro aminopeptidase 2,2658,318,0.91 [0.83-0.99],0.0294343580181415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,2300,272,1.79 [1.23-2.60],0.0022214567040301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YOD1,Ubiquitin thioesterase OTU1,2242,265,0.78 [0.64-0.94],0.0081003498383125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,2579,308,0.85 [0.74-0.98],0.0292653704731523
